Swedish snuff and incidence of cardiovascular disease. A population-based cohort study by Janzon, Ellis & Hedblad, Bo
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Cardiovascular Disorders
Open Access Research article
Swedish snuff and incidence of cardiovascular disease. A 
population-based cohort study
Ellis Janzon†1 and Bo Hedblad*†2
Address: 1Department of Health and Society, Malmö University, Malmö, Sweden and 2Department of Clinical Science, Research Groups of 
Cardiovascular Epidemiology Lund University, Malmö University Hospital, Malmö, Sweden
Email: Ellis Janzon - ellis.janzon@mah.se; Bo Hedblad* - bo.hedblad@med.lu.se
* Corresponding author    †Equal contributors
Abstract
Background: The relationship between smoking and an increased incidence of cardiovascular
diseases is well known. Whether smokeless tobacco (snuff) is related to myocardial infarction (MI)
or stroke is still controversial. Aim of this study was to explore whether snuff users have an
increased incidence of MI or stroke.
Methods: A total of 16 754 women and 10 473 men (aged 45–73 years), without history of
cardiovascular disease (CVD), belonging to the population-based "Malmö Diet and Cancer" study
were examined. Incidence of MI and stroke were monitored over 10.3 years.
Results: Snuff was used by 737 (7.0%) men and 75 (0.4%) women, respectively. Among men, snuff
was significantly associated with low occupation level, single civil status, high BMI and with current
and former smoking. In women, snuff was associated with lower systolic blood pressure. A total of
964 individuals (3.5%), i.e.544 men (5.3%) and 420 (2.5%) women suffered a MI during the follow-
up period. The corresponding numbers of incident stroke cases were 1048, i.e. 553 men (5.3%) and
495 (3.0%) women, respectively. Snuff was not associated with any statistically significant increased
risk of MI or stroke in men or women. The relative risks (RR) in male snuff users compared to non-
users were 1.05 (95% confidence interval (CI): 0.8–1.4, p = 0.740) for incident MI and 0.97 (0.7–
1.4, p = 0.878) for stroke, after taking age and potential confounders into account. In women none
of the 420 (2.5%) women who were snuff users had a MI and only one suffered a stroke during the
follow-up.
Conclusion: Several life-style risk factors were more prevalent in snuff-users than in non-users.
However, the present study does not support any relationship between snuff and incidence of
cardiovascular disease in men.
Background
The relationship between smoking and an increased inci-
dence of cardiovascular diseases (CVD) is well known.
Whether smokeless tobacco, in this study defined as snuff,
is related to incidence of CVD is less clear. Lately several
studies have explored the relationships between snuff and
CVD, and the results are not consistent [1-13]. In an ear-
lier study of construction workers, a significantly
increased risk of MI was reported among snuff users [7,8].
Snuff users also had a significantly higher prevalence of
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hypertension in that study [8]. In contrast, several other
studies from the general population found no relation-
ship between snuff and incidence of MI [2-5,10,12,13].
Some scientists have highlighted the need for more stud-
ies on snuff and incidence of CVD[1,2]. The purpose of
this population based cohort study was to explore
whether snuff users have an increased incidence of myo-
cardial infarction (MI) and stroke.
Methods
Subjects
The Malmö Diet and Cancer (MDC) cohort was used to
examine snuff use and its effect on incidence of CVD. All
subjects who were 45–73 years old, and who lived in the
city of Malmö, Sweden were invited. The health examina-
tion was performed at the Malmö University Hospital
from March 1991 to February 1996. The subjects were
invited by letters and advertisement in newspapers. Of the
eligible population of approximately 70 000 citizens, 28
449 subjects, i.e. 17 203 women and 11 246 men, respec-
tively participated. The participation rate was approxi-
mately 40% [14,15]. The MDC cohort and the
characteristics of the non-participants have been
described previously [15]. The representativeness of the
MDC study has been evaluated by a comparison with sub-
jects, in corresponding age groups, who participated in
1994 in a mailed questionnaire health survey in the city of
Malmö [15,16]. In that survey, non attendance was asso-
ciated with a lower prevalence of smoking and a higher
rate of mortality. However, prevalence of smoking and
obesity in the MDC was rather similar compared to the
mailed health study (prevalence of smoking 39.9%
vs.37.5% and 12.4% vs. 11.8% for prevalence of obesity,
respectively).
After exclusion of subjects with a history of MI or stroke,
and subjects with missing information about BMI, blood
pressure, diabetes or tobacco habits, the cohort consisted
of 27 227 individuals, 16 754 women and 10 473 men,
respectively. Mean age was 57.4 +7.6 years in women and
59.1+7.0 years in men.
Screening examination
Measurements of height (in cm), weight (in kilograms)
and blood pressure (in mmHg) were performed. The par-
ticipants also completed a comprehensive self-adminis-
tered questionnaire about life style habits and medical
history and treatment [14].
Smoking habits and use of snuff
Smoking was assessed in a self-administered question-
naire, and the subjects were categorized as never smokers,
ex-smokers and current smokers (regular or occasional
smokers). Daily cigarette consumption among current
smokers was assessed by the questions "how many ciga-
rettes do you smoke per day"?
Snuff use was assessed by the question "Do you use
snuff?" In subjects confirming the use of snuff the weekly
consumption of snuff was obtained by the question "How
many packages of snuff do you consume every week?" We
dichotomized weekly snuff consumption into three
groups: a) 1–2 packages per week as low consumption, b)
3–5 packages per week as medium consumption and c)
more than six packages per week as high consumption.
Chewing tobacco and use of nicotine gum
The habits of tobacco chewing and using nicotine gum
were obtained by the questions: ""Do you chew tobacco"
and "Do you use nicotine chewing gum?"
Hypertension
Blood pressure was measured twice in the supine position
after 10 minutes rest using a mercury sphygmomanome-
ter. Subjects who had systolic blood pressure (SBP) _140
Mm/Hg or diastolic blood pressure (DBP) _90 mmHg or
blood pressure-lowering drug treatment of hypertension
were considered to have hypertension [17].
Diabetes mellitus
Participants who reported that they had diabetes or who
used anti-diabetic medication was considered to have dia-
betes. As fasting blood glucose and lipids were available
only on subjects belonging to the cardiovascular project
(n = 5 500) [18], It was not possible to define diabetes on
all study subjects according to present or previous recom-
mendations for classification of diabetes mellitus [19].
Body mass index (BMI)
BMI was calculated as weight/height2 (kg/m2).
Physical activity
Physical activity during leisure time was revealed through
18 questions covering a range of activities in the four sea-
sons. The number of minutes per week for each activity
was multiplied by an intensity coefficient, and an overall
leisure time physical activity scores was created. Scores
were divided into four quartiles and subsequently catego-
rized as a) low (quartile 1), b) moderate (quartile 2 to 3),
and c) high (quartile 4) levels [20].
Information on socio-economic circumstances
Information on occupation and marital status was
assessed by the questionnaire. The categorization into
occupational groups based on the Swedish socio-eco-
nomic index (SEI) [21] has been presented previously
[22,23]. This classification takes into consideration the
educational level needed for the job, the level of responsi-
bility in the work organization as well as the actual workBMC Cardiovascular Disorders 2009, 9:21 http://www.biomedcentral.com/1471-2261/9/21
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task [22]. In this study data were dichotomized into four
groups only, due to few cases. High and medium levels
non-manual employees was dichotomized into the same
group as "High occupational level" (SEI groups 46–69)",
and contained the following groups: high level (i.e., busi-
ness executives, university-engineers and teachers) and
medium level employees (i.e., reg. nurses, employees,
computer operators and high school teachers).
Low-level non-manual employees (SEI groups 33–36, i.e.
office assistants, sales staff and secretaries, etc) were cate-
gorized as "Medium occupation level".
Skilled manual workers, unskilled workers and unspeci-
fied occupational groups (i.e. early retired women, house-
wives, students and unemployed) (SEI groups 11–22)
were categorized as "low level occupational". The group
"others" contained self employed* and farmers i.e. (SEI
groups 70–99) [22,23].
Marital status
The questionnaire had the following four categories: Mar-
ried, unmarried, divorced and widowed. In accordance
with previous studies we dichotomized the cohort into
the status living alone or not [22].
Education
Education level was assessed in the questionnaire as pre-
viously described and divided into low (9 years education
or less) and high education level (at least secondary grad-
uation). The dichotomized variable education was used in
the analyses [22].
Incidence of stroke and MI
Each participant was followed from the baseline examina-
tion until the first incident MI or stroke event, death, emi-
gration out of Sweden, or Dec 31, 2004, whichever came
first.
Incident stroke was defined as ICD-9 codes 430, 431, 434
and 436 [24,25]. MI was defined as nonfatal MI (ICD-9
code 410) or fatal ischemic heart disease (ICD-9 code
410–414). The National hospital discharge register, the
Stroke register of Malmö [26] and the Swedish hospital
discharge register were used for case retrieval.
Statistics
The Cox proportional hazards model was used to assess
the relationship between snuff use and incidence of MI
and stroke, respectively. The Cox model was also used to
adjust the relationships for other risk factors. One way
analyses of variance and logistic regression was used to
compare risk factor in users and non-users of snuff. A gen-
eral linear model was used to adjust the mean values (i.e.,
blood pressure and BMI) for other risk factors
Results
Snuff was used by a total of 812 individuals, i.e. 737
(7.0%) men and 75 (0.4%) women, respectively. Of those
subjects 764 (94.1%) reported weekly snuff packages con-
sumption. Among men 54.5% (n = 402) were categorized
as low, 32.2% (n = 237) as medium and 9.0% (n = 66) as
high consumers. The corresponding figures among
women were 58.7% (n = 44), 14.7% (n = 11) and 0.1% (n
= 4), respectively.
Chewing tobacco was unusual in this cohort, being
reported by only 96 persons (0.4%). Nicotine gum was
used by a total of 497 individuals (1.8%), i.e. 131
(26.4%) men and 364 (73.6%) women, respectively data
not presented in tables.
Snuff, smoking habits and cardiovascular risk factors
The distribution of risk factors in users and non-users of
snuff is presented in Table 1. Mean age for snuff users
was significantly lower in both men and women com-
pared to non-users. Smoking and former smoking was
more common in snuff-users compared to non-users.
However, the mean daily cigarette consumption (in
grams) in snuff users compared to non-users was signif-
icantly lower both among male and female current
smokers. Former smoking was also higher among snuff-
users compared to non-users, significantly only for men.
Very few never smokers reported use of snuff (i.e. 67 men
and 27 women). BMI was slightly higher in male snuff
users, and this relationship remained significant after
adjustment for age [adjusted means ± standard error of
the mean; 26.2 ± 0.035 vs. 26.6 ± 0.013 kg/m2]. In men,
blood pressure was rather similar in snuff users and non-
users, however, prevalence of blood pressure lowering
treatment was significantly lower in male snuff-users
(i.e. 14.9% vs. 18.5%, p = 0.016) [Table 1]. Female snuff
users had statistically significant lower systolic blood
pressure and prevalence of hypertension than non-users.
These relationships were markedly attenuated and
became non-significant after taking age and BMI into
account (data not shown) In addition to that, fewer male
snuff users than non-users were currently on treatment
with blood pressure lowering agents (i.e. 14.9% vs.
18.5%, p = 0.016 for men, and 9.3% vs. 15.7%, p = 0.129
for women [Table 1].
Snuff and socio-demographic risk factors
Significantly more male snuff users than non-users were
living alone and categorized as belonging to the low-
level occupational group. Among women, however, the
proportion that was categorized as belonging to low-
level occupational group was lower among snuff users
compared to non-users 25.2% vs. 44.3%, p= 0.122
[Table 1].BMC Cardiovascular Disorders 2009, 9:21 http://www.biomedcentral.com/1471-2261/9/21
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Incidence of cardiovascular disease
During the follow-up period a total of 544 (5.3%) men
had MI and 553 (5.3%) had stroke. The corresponding
figures for women were 420 (2.5%) for MI and 495
(3.0%) for stroke (data not shown I tables).
In men, snuff use was not significantly related to risk of
incident MI during the follow-up period, whether adjust-
ment was made for age only (relative risk, RR = 0.89, 95%
confidence interval CI: 0.7–1.2), or when taking other risk
factors into account (RR: 1.05; 95% CI: 0.8–1.4 [Table 2].
In men who used snuff, the age-adjusted RR for stroke was
0.88, 95% CI: 0.6–1.2. This RR remained quite similar
after taking other risk factors into account (RR: 0.97; 95%
CI: 0.7–1.4 [Table 2]. No significant relationship between
snuff and incidence of MI or stroke was observed in any of
the categories of smoking. However, the number of MI
and stroke were very small among snuff users who never
had smoked (n = 4 and n = 4, respectively).
None of the 420 women who suffered a MI were snuff
users. Furthermore, there was only one stroke case among
female snuff users. As the number of events was based on
only one case no further statistical analysis was performed
on this matter among women.
The age-adjusted RR for incident MI was 1.5 times higher
(95% CI: 0.5–4.5, p = 0.512) in men who chew tobacco
than in men who used snuff. After further adjustment for
other risk factors it was even higher (RR: 1.7, 95% CI: 0.5–
5.2, p = 0.368, data not shown in tables). The RR for MI
in tobacco chewing women was not evaluated due to
small numbers.
Discussion
It is well known, and well accepted, that tobacco smoke
has many negative health effects [27,28]. The effects of
smokeless tobacco, snuff, on health are less well explored,
though lately more studies have been published [1-13,29-
31]. Fewer studies have explored the association between
snuff and CVD, and to our knowledge, there are only few
studies on women [3,10]. During the 10-year follow-up
only one of the 75 female snuff users suffered a stroke and
none a MI. Because of these small numbers in females,
our analyses are restricted to males. The present study
does not support the hypothesis that snuff is a risk factor
for incident myocardial infarction or stroke in men. We
Table 1: Distributions of risk factors in 27 227 individuals in relation to smokeless tobacco (snuff)
Men (n = 10 473) Women (n = 16 754)
Snuff non users 
(n = 9 736)
Snuff users (n = 737) P value Snuff non users 
(n = 16 679)
Snuff users (n = 75) P value
Age (years) 59.2 ± 7.6 56.8 ± 6.7 <0.001 57.4 ± 7.9 54.6 ± 7.2 0.002
Blood pressure 
(BP, mm Hg)
Systolic 143.9 ± 19.3 143.0 ± 19.3 0.227 139.2 ± 20.2 134.4 ± 21.2 0.040
Diastolic 88.0 ± 9.8 88.2 ± 9.9 0.587 84.0 ± 9.7 82.0 ± 10.4 0.090
Hypertension, % (n) 65.2 (6351) 65.8 (485) 0.708 53.2 (8872) 37.3 (28) 0.006
Use of BP lowering 
treatment, % (n)
14.9 (110) 0.016 15.7 (2623) 9.3 (7) 0.129
BMI (kg/m2) 26.2 ± 3.5 26.6 ± 3.5 0.004 25.4 ± 4.2 25.1 ± 3.9 0.528
Diabetes mellitus %(n) 3.9 (368) 3.9 (29) 0.832 2.4 (398) 1.3 (1) 0.551
Smoking habits
Never smoker, % (n) 30.3 (2946) 9.1 (67) 0.000 44.4 (7404) 36.0 (27) 0.144
Ex-smoker, % (n) 41.2 (4014) 57.0 (420) 0.000 27.6 (4599) 36.0 (27) 0.103
Current smoker,%(n) 28.5 (2776) 33.9 (250) 0.002 28.0 (4676) 28.0 (21) 0.995
Daily (grs) cigarette 
consumption by current 
smokers
16.1 ± 9.0 12.3 ± 9.7 0.001 12.9 ± 7.1 7.8 ± 6.4 0.001
Occupational status
Low level, % (n) 45.4 (3866) 57.0 (369) 0.000 44.3 (6522) 25.2 (25) 0.122
Medium level, % (n) 18.0 (1532) 13.8 (89) 0.007 20.0 (2944) 23.9 (17) 0.409
High level, % (n) 14.5 (1234) 11.3 (73) 0.025 14.2 (2092) 22.5 (16) 0.460
Others, % (n) 22.2 (1889) 17.9 (116) 0.212 21.4 (3151) 18.3 (13) 0.524
Civil status
Single, % (n) 27.0 (2630) 32.6 (240) 0.001 39.2 (6545) 46.7 (35) 0.117
Values are shown as mean ± SD unless otherwise stated. For occupational status percentages are of numbers classifiableBMC Cardiovascular Disorders 2009, 9:21 http://www.biomedcentral.com/1471-2261/9/21
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also could not confirm previously reported findings that
snuff users have higher blood pressure than non-users [8].
Snuff users generally had lower occupation level, among
men, and were more often single and current or former
smokers than non-users of snuff. BMI was somewhat
higher in male snuff users. There was, however, no indica-
tion of any significant relationship between snuff and an
increased prevalence of hypertension or diabetes. Mean
blood pressure showed no statistically significant differ-
ence between male or female snuff users and non-users
after taking age and BMI into account. The absence of a
relationship between snuff use and high blood pressure is
in accordance with results from other studies discussed in
a review study by Lee 2007 [5] but in contrast to a study
of construction workers [8].
Both smoking and smokeless tobacco have been associ-
ated with lower weight [31]. In this study male snuff users
had higher BMI than non-users, which remained after
adjustment for age and smoking habits. No difference was
observed in women. Because snuff often is used by smok-
ers who try to quit, and smoking cessation is associated
with weight gain, this could be one explanation for the
difference in BMI in men. It is well known that women
often use smoking to control weight, but weight regula-
tion does not seem to be a common reason for using
smokeless tobacco [32,33].
One question is whether the statistical power was ade-
quate to detect a relationship between snuff and incidence
of CVD. Bolinder et al [8] reported that the age-adjusted
RR of CVD was approximately 1.4 (95% CI: 1.2–1.6) for
snuff users compared to non-users. If the risk associated
with snuff had been of that magnitude, our probability of
detecting a significant difference in incidence of MI would
be about 75%. The statistical power for a combined end-
point of MI and stroke in the present study would be
about 90%. We therefore believe that the statistical power
of our study was adequate.
The MDC cohort was used in the present study. The par-
ticipation rate was low in this cohort, approximately 40%
[15]. However, when comparing the present cohort with
results from a health survey based on a mailed question-
naire to subjects living in the city of Malmö 1994, in
which the participation rates were 80%, it has been shown
that the present cohort is fairly representative with respect
to e.g., smoking habits and BMI [16]. The mortality rates
Table 2: Incidence of and RR (95% CI) for MI and stroke in relation to snuff in men
Smokeless tobacco (snuff)
No N = 9736 Yes N = 737 P value
MI n (%) All 511 (5.2) 33 (4.5)
Never smokers 114 (3.9) 4 (6.0)
Ex-smokers 180 (4.5) 15 (3.6)
Smokers 217 (7.8) 14 (5.6)
Age-adjusted RR All 1.0 0.89 (0.7–1.2) 0.408
Never smokers 1.0 0.61 (0.2–1.5) 0.280
Ex-smokers 1.0 0.79 (0.5–1.2) 0.251
Smokers 1.0 1.2 (0.8–1.9) 0.393
Risk factor adjusted* All 1.0 1.05 (0.8–1.4) 0.740
Never smokers 1.0 0.75 (0.3–1.8) 0.532
Ex-smokers 1.0 0.81 (0.5–1.2) 0.304
Smokers 1.0 1.31 (0.8–2.0) 0.236
Stroke n (%) All 518 (5.3) 35 (3.5)
Never smokers 136 (4.6) 4 (6.0)
Ex-smokers 211 (5.3) 18 (4.3)
Smokers 171 (6.2) 13 (5.2)
Age-adjusted RR All 1.0 0.88 (0.6–1.2) 0.470
Never smokers 1.0 0.54 (0.2–1.8) 0.226
Ex-smokers 1.0 0.91 (0.6–1.5) 0.719
Smokers 1.0 1.03 (0.6–1.8) 0.929
Risk factor adjusted* All 1.0 0.97 (0.7–1.4) 0.878
Never smokers 1.0 0.59 (0.2–1.5) 0.311
Ex-smokers 1.0 0.88 (0.5–1.4) 0.632
Smokers 1.0 1.13 (0.6–2.0) 0.663
* adjusted for age, BMI, smoking habits, diabetes mellitus, hypertension, physical activity, marital status and occupation, RR, relative risk and 95% 
confidence interval.BMC Cardiovascular Disorders 2009, 9:21 http://www.biomedcentral.com/1471-2261/9/21
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in the study by Manjer et al were, however, higher among
non-participants.
The results from the present study are similar to what has
been reported from other population-based studies [2-
4,6,10,12,13] and in contrast to some other Swedish stud-
ies [7,8]. As use of snuff historically has been closely asso-
ciated to inferior socioeconomic position, it cannot be
ruled out that the differences between the present study
and the results of males by Bolinder et al [8] could be
explained by differences in study populations and time
periods. Ramstrom et al, [29] stated that people who stop
smoking often start using snuff and reported that 58%
used snuff as an aid to stop smoking. Furthermore, many
continued to use snuff after smoking cessation. In the
study by Huhtasaari et al, 50% of snuff users were former
smokers [12]. In this present study we also found 57%
snuff users among male ex-smokers. This fact sometimes
causes frustration in caregivers and public health profes-
sionals. Whether snuff should be used as a device to stop
smoking is intensively debated in Sweden. On one hand,
there is no doubt that the health hazard of snuff is consid-
erably smaller than that of smoking. On the other hand,
there are several other nicotine based products for tobacco
cessation and we cannot exclude the possibility that snuff
could increase the risk of cancer [27,28]. In our opinion,
more studies are needed to fully clarify the effects of snuff,
especially in women, during pregnancy and in older indi-
viduals. It is important that information about snuff given
to patients and the general public is accurate and reliable.
All findings should be reported in order to increase the
knowledge about the health effects of snuff.
Conclusion
Even though some life-style risk factors seem to be more
prevalent in snuff-users, the present study does not sup-
port any independent relationship between snuff and
incidence of MI or stroke in men.
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